Scientists at the Centre have developed a new antibody that could hold the key to unlocking cancer’s defence against the body’s immune system.
The Centre for Cancer Immunology is leading a world-first trans-Atlantic clinical trial that will test a new three-part treatment and give children with an aggressive form of cancer new hope in their fight against the disease.
A cancer scientist from the Centre for Cancer Immunology has been recognised for her research that could dramatically improve lymphoma survival.
World-leading immunologist Professor Freda Stevenson, from the Centre for Cancer Immunology, will be recognised by The American Society of Hematology (ASH) with the 2018 Henry M. Stratton Medal for her seminal contribution to haematology research.
The Centre for Cancer Immunology is delighted to welcome Professors Sally Ward and Raimund Ober who will be heading up a joint multidisciplinary laboratory.
Scientists at the University of Southampton including those at the Centre for Cancer Immunology have developed a new method to understand how antibodies move in solution, which will help in their fight against cancer.
We are thrilled to announce we have reached our target of raising £25m for our new Centre for Cancer Immunology. Thanks to an overwhelming response from donors, fundraisers and supporters, across the UK and internationally, we have reached our campaign goal six months ahead of schedule.
This World Cancer Day, please join us in supporting our Centre for Cancer Immunology by wearing white and sharing your photos on social media using #WearingWhite 1-4 February 2018. You’ll be helping us spread the word about our life-saving research and our new world-leading Centre.
We are delighted to announce that we have now raised £24m for our new Centre – leaving just £1m to go to reach the final target by next summer! Thank you to all our supporters for helping us end this year on such a high.
A University of Southampton study has found that combining two different immunotherapy treatments could dramatically improve lymphoma survival.
Dr Sean Lim, who led the study, said: “By combining two specific antibodies we’ve increased the ability of the immune system to destroy cancer cells. It’s very exciting to see that this drug combination has an impact on survival.”